Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

In 2020, West Virginia started a pilot program providing subsidies for GLP-1 weight loss drugs for state employees. It showed ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

Allurion's new program uses artificial intelligence guidance to help patients adhere to a well-rounded diet and exercise ...

Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American adults would ...

Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...

By Christopher Gannatti, CFAIn November 2024, it isn’t difficult to find all sorts of perspectives on the so-called ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

Hims & Hers shares have gyrated this year after the company started offering copycat versions of GLP-1 injections that are ...